Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors.

Louveau B, Delyon J, De Moura CR, Battistella M, Jouenne F, Golmard L, Sadoux A, Podgorniak MP, Chami I, Marco O, Caramel J, Dalle S, Feugeas JP, Dumaz N, Lebbe C, Mourah S.

Oncotarget. 2019 Mar 1;10(18):1669-1687. doi: 10.18632/oncotarget.26707. eCollection 2019 Mar 1.

2.

Tspan8-β-catenin positive feedback loop promotes melanoma invasion.

El Kharbili M, Agaësse G, Barbollat-Boutrand L, Pommier RM, de la Fouchardière A, Larue L, Caramel J, Puisieux A, Berthier-Vergnes O, Masse I.

Oncogene. 2019 May;38(20):3781-3793. doi: 10.1038/s41388-019-0691-z. Epub 2019 Jan 24.

PMID:
30679790
3.

Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells.

Leclerc J, Garandeau D, Pandiani C, Gaudel C, Bille K, Nottet N, Garcia V, Colosetti P, Pagnotta S, Bahadoran P, Tondeur G, Mograbi B, Dalle S, Caramel J, Levade T, Ballotti R, Andrieu-Abadie N, Bertolotto C.

Oncogene. 2019 Feb;38(8):1282-1295. doi: 10.1038/s41388-018-0500-0. Epub 2018 Sep 25.

PMID:
30254208
4.

Pleiotropic Roles for ZEB1 in Cancer.

Caramel J, Ligier M, Puisieux A.

Cancer Res. 2018 Jan 1;78(1):30-35. doi: 10.1158/0008-5472.CAN-17-2476. Epub 2017 Dec 18. Review.

5.

Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date.

Boespflug A, Caramel J, Dalle S, Thomas L.

Ther Adv Med Oncol. 2017 Jul;9(7):481-492. doi: 10.1177/1758834017708160. Epub 2017 May 29. Review.

6.

A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.

Morel AP, Ginestier C, Pommier RM, Cabaud O, Ruiz E, Wicinski J, Devouassoux-Shisheboran M, Combaret V, Finetti P, Chassot C, Pinatel C, Fauvet F, Saintigny P, Thomas E, Moyret-Lalle C, Lachuer J, Despras E, Jauffret JL, Bertucci F, Guitton J, Wierinckx A, Wang Q, Radosevic-Robin N, Penault-Llorca F, Cox DG, Hollande F, Ansieau S, Caramel J, Birnbaum D, Vigneron AM, Tissier A, Charafe-Jauffret E, Puisieux A.

Nat Med. 2017 May;23(5):568-578. doi: 10.1038/nm.4323. Epub 2017 Apr 10.

PMID:
28394329
7.

ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.

Richard G, Dalle S, Monet MA, Ligier M, Boespflug A, Pommier RM, de la Fouchardière A, Perier-Muzet M, Depaepe L, Barnault R, Tondeur G, Ansieau S, Thomas E, Bertolotto C, Ballotti R, Mourah S, Battistella M, Lebbé C, Thomas L, Puisieux A, Caramel J.

EMBO Mol Med. 2016 Oct 4;8(10):1143-1161. doi: 10.15252/emmm.201505971. Print 2016 Oct.

8.

Dermoscopic Evaluation of Melanocytic Nevi Changes With Combined Mitogen-Activated Protein Kinase Pathway Inhibitors Therapy for Melanoma.

Perier-Muzet M, Boespflug A, Poulalhon N, Caramel J, Breton AL, Thomas L, Dalle S.

JAMA Dermatol. 2016 Oct 1;152(10):1162-1164. doi: 10.1001/jamadermatol.2016.2426. No abstract available.

PMID:
27463731
9.

The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells.

Jacqueroud L, Bouard C, Richard G, Payen L, Devouassoux-Shisheboran M, Spicer DB, Caramel J, Collin G, Puisieux A, Tissier A, Ansieau S.

Neoplasia. 2016 May;18(5):317-327. doi: 10.1016/j.neo.2016.03.007.

10.

The transcription factor E4F1 coordinates CHK1-dependent checkpoint and mitochondrial functions.

Rodier G, Kirsh O, Baraibar M, Houlès T, Lacroix M, Delpech H, Hatchi E, Arnould S, Severac D, Dubois E, Caramel J, Julien E, Friguet B, Le Cam L, Sardet C.

Cell Rep. 2015 Apr 14;11(2):220-33. doi: 10.1016/j.celrep.2015.03.024. Epub 2015 Apr 2.

11.

Oncogenic roles of EMT-inducing transcription factors.

Puisieux A, Brabletz T, Caramel J.

Nat Cell Biol. 2014 Jun;16(6):488-94. doi: 10.1038/ncb2976. Review.

PMID:
24875735
12.

Plasticity of melanoma and EMT-TF reprogramming.

Tulchinsky E, Pringle JH, Caramel J, Ansieau S.

Oncotarget. 2014 Jan 15;5(1):1-2. No abstract available.

13.

A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.

Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G, Wierinckx A, Saldanha G, Osborne J, Hutchinson P, Tse G, Lachuer J, Puisieux A, Pringle JH, Ansieau S, Tulchinsky E.

Cancer Cell. 2013 Oct 14;24(4):466-80. doi: 10.1016/j.ccr.2013.08.018. Epub 2013 Sep 26.

14.

E4F1 deficiency results in oxidative stress-mediated cell death of leukemic cells.

Hatchi E, Rodier G, Lacroix M, Caramel J, Kirsh O, Jacquet C, Schrepfer E, Lagarrigue S, Linares LK, Lledo G, Tondeur S, Dubus P, Sardet C, Le Cam L.

J Exp Med. 2011 Jul 4;208(7):1403-17. doi: 10.1084/jem.20101995. Epub 2011 Jun 27.

15.

E4F1 connects the Bmi1-ARF-p53 pathway to epidermal stem cell-dependent skin homeostasis.

Caramel J, Lacroix M, Le Cam L, Sardet C.

Cell Cycle. 2011 Mar 15;10(6):866-7. Epub 2011 Mar 15. No abstract available.

PMID:
21336028
16.

Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasis.

Lacroix M, Caramel J, Goguet-Rubio P, Linares LK, Estrach S, Hatchi E, Rodier G, Lledo G, de Bettignies C, Thépot A, Deraison C, Chébli K, Hovnanian A, Hainaut P, Dubus P, Sardet C, Le Cam L.

Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21076-81. doi: 10.1073/pnas.1010167107. Epub 2010 Nov 18. Erratum in: Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14716.

17.

RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.

Caramel J, Quignon F, Delattre O.

Cancer Res. 2008 Aug 1;68(15):6154-61. doi: 10.1158/0008-5472.CAN-08-0115.

18.

The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.

Caramel J, Medjkane S, Quignon F, Delattre O.

Oncogene. 2008 Mar 27;27(14):2035-44. Epub 2007 Oct 8.

PMID:
17922027
19.

The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription.

Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Lévy L, Buendia MA, Neuveut C.

J Biol Chem. 2007 Feb 16;282(7):4277-87. Epub 2006 Dec 11.

20.

The oculomotor nerve: biometry and endoneural fascicular systematization.

Caramel JP, Bonnel F, Rabischong P.

Anat Clin. 1983;5(3):159-68.

PMID:
6671061

Supplemental Content

Loading ...
Support Center